Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cataplexy.

Paul Reading1

  • 1Department of Neurology, The James Cook University Hospital, Middlesbrough TS4 3BW, UK p.reading@nhs.net.

Practical Neurology
|October 26, 2018
PubMed
Summary
This summary is machine-generated.

Cataplexy, a symptom of narcolepsy type 1, stems from hypocretin neuron loss. This condition involves REM sleep paralysis intruding into wakefulness, often triggered by emotions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological management of narcolepsy in children and adolescents.

Journal of sleep research·2023
Same author

European guideline and expert statements on the management of narcolepsy in adults and children.

Journal of sleep research·2021
Same author

European guideline and expert statements on the management of narcolepsy in adults and children.

European journal of neurology·2021
Same author

Bell's that did not ring true.

Practical neurology·2017
Same author

Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England.

Sleep·2016
Same author

Treating restless legs syndrome with rotigotine.

British journal of hospital medicine (London, England : 2005)·2010
Same journal

Recurrent falls while taking clozapine.

Practical neurology·2026
Same journal

Anti-Ma2 encephalitis: when the examination localises beyond MRI.

Practical neurology·2026
Same journal

Oculopharyngeal muscular dystrophy: diagnosis, management and multisystem care.

Practical neurology·2026
Same journal

Neurological signs of possible diagnostic value in the cognitive clinic: past, present and future.

Practical neurology·2026
Same journal

Longitudinally extensive myelitis in neurosarcoidosis.

Practical neurology·2026
Same journal

Patient with bilateral horizontal gaze palsy.

Practical neurology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Sleep Medicine
  • Neurology

Background:

  • Cataplexy, a core symptom of narcolepsy type 1, is linked to the loss of hypocretin-producing neurons in the lateral hypothalamus.
  • It manifests as inappropriate intrusion of REM sleep atonia into wakefulness, causing muscle paralysis.
  • Emotional triggers commonly precipitate cataplexy episodes, significantly impacting daily life.

Purpose of the Study:

  • To explore the neurobiological underpinnings of cataplexy in narcolepsy type 1.
  • To review the clinical presentation and management strategies for cataplexy.
  • To discuss the relationship between hypocretin deficiency, emotional processing, and REM sleep regulation.

Main Methods:

  • Literature review and synthesis of existing research on narcolepsy type 1 and cataplexy.

Related Experiment Videos

  • Analysis of the neurobiological mechanisms involving hypocretin and REM sleep.
  • Examination of current and emerging pharmacological treatments.

    • Main Results:

    • Cataplexy is strongly associated with a significant loss of hypocretin neurons.
    • REM sleep dysregulation is central to the pathophysiology of cataplexy.
    • Antidepressants and sodium oxybate are established treatments, while pitolisant offers a novel approach.

    Conclusions:

    • Understanding hypocretin deficiency's role in cataplexy offers insights into emotional processing and sleep control.
    • Further research into cataplexy's neurobiology can refine treatment strategies for narcolepsy.
    • Targeting hypocretin pathways may hold therapeutic potential for sleep and emotional disorders.